The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study
Scottish Diabetes Research Network Epidemiology Group, Stuart J. McGurnaghan, Liam Brierley, Thomas M. Caparrotta, Paul M. McKeigue, Luke A. K. Blackbourn, Sarah H. Wild, Graham Leese, Rory McCrimmon, John A. McKnight, Ewan Pearson, John R. Petrie, Naveed Sattar, Helen M. Colhoun
Dive into the research topics of 'The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study'. Together they form a unique fingerprint.